SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-20-004292
Filing Date
2020-04-24
Accepted
2020-04-24 16:30:48
Documents
9
Period of Report
2020-06-09
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20200609xdef14a.htm DEF 14A 1221387
2 GRAPHIC tmb-20200609xdef14ag001.jpg GRAPHIC 7501
3 GRAPHIC tmb-20200609xdef14ag002.jpg GRAPHIC 5669
4 GRAPHIC tmb-20200609xdef14ag003.jpg GRAPHIC 5701
5 GRAPHIC tmb-20200609xdef14ag004.jpg GRAPHIC 2537
6 GRAPHIC tmb-20200609xdef14ag005.jpg GRAPHIC 2407
7 GRAPHIC tmb-20200609xdef14ag006.jpg GRAPHIC 2523
8 GRAPHIC tmb-20200609xdef14ag007.gif GRAPHIC 34466
9 GRAPHIC tmb-20200609xdef14ag008.gif GRAPHIC 56322
  Complete submission text file 0001558370-20-004292.txt   1384949
Mailing Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715
Business Address 101 POOR FARM ROAD PRINCETON NJ 08540-1715 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36464 | Film No.: 20815481
SIC: 2834 Pharmaceutical Preparations